Natural history of neuromodulation devices and therapies: A patient-centered survival analysis

Zoe E. Teton, Daniel Blatt, Amr AlBakry, James Obayashi, Gulsah Ozturk, Vural Hamzaoglu, Philippe Magown, Nathan R. Selden, Kim J. Burchiel, Ahmed M. Raslan

Research output: Contribution to journalArticle

Abstract

OBJECTIVE Despite rapid development and expansion of neuromodulation technologies, knowledge about device and/ or therapy durability remains limited. The aim of this study was to evaluate the long-term rate of hardware and therapeutic failure of implanted devices for several neuromodulation therapies. METHODS The authors performed a retrospective analysis of patients’ device and therapy survival data (Kaplan-Meier survival analysis) for deep brain stimulation (DBS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS) at a single institution (years 1994–2015). RESULTS During the study period, 450 patients underwent DBS, 383 VNS, and 128 SCS. For DBS, the 5- and 10-year initial device survival was 87% and 73%, respectively, and therapy survival was 96% and 91%, respectively. For VNS, the 5- and 10-year initial device survival was 90% and 70%, respectively, and therapy survival was 99% and 97%, respectively. For SCS, the 5- and 10-year initial device survival was 50% and 34%, respectively, and therapy survival was 74% and 56%, respectively. The average initial device survival for DBS, VNS, and SCS was 14 years, 14 years, and 8 years while mean therapy survival was 18 years, 18 years, and 12.5 years, respectively. CONCLUSIONS The authors report, for the first time, comparative device and therapy survival rates out to 15 years for large cohorts of DBS, VNS, and SCS patients. Their results demonstrate higher device and therapy survival rates for DBS and VNS than for SCS. Hardware failures were more common among SCS patients, which may have played a role in the discontinuation of therapy. Higher therapy survival than device survival across all modalities indicates continued therapeutic benefit beyond initial device failures, which is important to emphasize when counseling patients.

Original languageEnglish (US)
Pages (from-to)1385-1391
Number of pages7
JournalJournal of neurosurgery
Volume132
Issue number5
DOIs
StatePublished - May 2020

Keywords

  • Device
  • Functional neurosurgery
  • Neuromodulation
  • Survival
  • Technology
  • Therapy

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Natural history of neuromodulation devices and therapies: A patient-centered survival analysis'. Together they form a unique fingerprint.

  • Cite this

    Teton, Z. E., Blatt, D., AlBakry, A., Obayashi, J., Ozturk, G., Hamzaoglu, V., Magown, P., Selden, N. R., Burchiel, K. J., & Raslan, A. M. (2020). Natural history of neuromodulation devices and therapies: A patient-centered survival analysis. Journal of neurosurgery, 132(5), 1385-1391. https://doi.org/10.3171/2019.2.JNS182450